Tomas Kramar

Tomas Kramar is a seasoned professional with extensive experience in leadership roles across various companies and organizations. As a Founding Partner at Kramar Group since June 2019, Tomas Kramar also serves as a board member at Nanologica AB, SpectraCure AB, Corsmed, and Deep Light Vision AB, while holding the position of Chairman at Cardeon AB and Percy Falk Foundation. Additionally, Tomas Kramar has a background in strategic management from previous experience as CEO of Siemens Healthineers in Sweden from October 2015 to August 2019. With a Master of Science in Chemistry from The Faculty of Engineering at Lund University, obtained between 1973 and 1979, Tomas Kramar's expertise spans multiple sectors, contributing significantly to innovation and governance in the life sciences and technology fields.